Urine could be a source of tumor DNA for detecting prostate and bladder cancer, though hypermethylation of glutathione S-transferase P1 (GSTP1) or other gene panels (e.g., RASSF1A, APC, p14) do not have sufficient sensitivity in detecting early stage disease [117,118]. Here, RASSF1 is linked to urinary bladder carcinoma.